Utilizing Clinical Research Organizations for late Phase I studies

Utilizing Clinical Research Organizations for late Phase I studies

A key step in developing a new drug is the transition from the laboratory to the human subject in a Phase I clinical trial, where the new compound is given to humans for the first time. A Phase I trial is the gateway between scientific research and clinical medicine. Generally, in-human Phase I studies are […]

Read More

January 4th, 2017

Cross Collaboration with CRO and Phase I Unit

A Phase I study is the first time a new drug or treatment procedure is tested in-humans. The purpose of this phase is to determine the metabolism and pharmacologic actions of the drug in-humans, the side effects associated with increasing doses, and, if possible, to gain early evidence on effectiveness. Phase I studies in-human participants […]

Read More

October 26th, 2016

required
required
required
required
I wish to subscribe to George Clinical communications.
required

Add George Clinical to your network